Development of specification for substance 7-azepan-1- il-1-ethil-6-ftor-3- (4-phenyl-1, 3-tiazol-2-il) - Quinoline- 4 (1h)-one
Loading...
Date
Authors
Spyrydonova, N.
Silin, A.
Lebedynets, Vyacheslav
Zavada, O.
Kalinenko, Olga
Journal Title
Journal ISSN
Volume Title
Publisher
Editor(s)
Abstract
The paper presents the results of the development of specifications for a new first-synthesized chemical
compound exhibiting antibacterial activity and positioned as a perspective drug substance. According to
the recommendations of the European Pharmacopoeia quality control procedures have been developed
for standardization the substance of 7-azepan-1-yl-1-ethyl-6-fluoro-3-(4-phenyl-1,3-thiazol-2-yl))-
quinoline-4(1H)-one - a modified derivative of the fluoroquinolone series.
Description
Citation
Development of specification for substance 7-azepan-1- il-1-ethil-6-ftor-3- (4-phenyl-1, 3-tiazol-2-il) - Quinoline- 4 (1h)-one / N. V. Spyrydonova, A. V. Silin, V. A. Lebedynets, O. A. Zavada, O. S. Kalinenko // The Pharma Innovation Journal. – 2019. – V. 8 (5). – P. 54–56.